Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aveeno cleansers are a line of topical skincare products developed by **Kenvue** (formerly Johnson & Johnson) specifically formulated for sensitive, dry, or atopic skin. These products are characterized by the inclusion of prebiotic oat (colloidal oatmeal), which serves to soothe irritation and support the skin's natural moisture barrier. Formulated to be soap-free and hypoallergenic, Aveeno cleansers utilize mild surfactants to remove impurities without disrupting the skin's lipid layer. Clinical studies, including those presented at the AAD, have demonstrated that these cleansers are more effective than water alone at maintaining skin hydration and facilitating transepidermal water loss (TEWL) recovery in patients with atopic dermatitis (eczema).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aveeno cleanser.